Innate immune regulation in HIV latency models

• Published in: Retrovirology 2022-07, Vol.19 (1), p.15-15, Article 15
• Main Authors: Olson, Rebecca M, Gornalusse, Germán, Whitmore, Leanne S, Newhouse, Dan, Tisoncik-Go, Jennifer, Smith, Elise, Ochsenbauer, Christina, Hladik, Florian, Gale, Jr, Michael
• Format: Article
• Language: English
• Subjects: Analysis; Antiretroviral therapy; Antiviral Agents; Biological products industry; Biological response modifiers; CD4 antigen; CD4-Positive T-Lymphocytes; Cell culture; Cell lines; Control; Genomics; Health aspects; Highly active antiretroviral therapy; HIV; HIV (Viruses); HIV infection; HIV Infections; Human immunodeficiency virus; Humans; Immunity, Innate; Immunoregulation; Immunotherapy; Infection; Infection control; Infections; Innate immunity; Interferon; Interferon Type I - metabolism; Interferon-stimulated gene; Latency; Latent infection; Lymphocytes; Lymphocytes T; Pathogens; Proteins; Reservoir; RNA; RNA sequencing; Scientific equipment and supplies industry; T cells; Virus Latency; Viruses
• ISSN: 1742-4690; 1742-4690
• DOI: 10.1186/s12977-022-00599-z

Innate immunity and type 1 interferon (IFN) defenses are critical for early control of HIV infection within CD4 + T cells. Despite these defenses, some acutely infected cells silence viral transcription to become latently infected and form the HIV reservoir in vivo. Latently infected cells persist through antiretroviral therapy (ART) and are a major barrier to HIV cure. Here, we evaluated innate immunity and IFN responses in multiple T cell models of HIV latency, including established latent cell lines, Jurkat cells latently infected with a reporter virus, and a primary CD4 + T cell model of virologic suppression. We found that while latently infected T cell lines have functional RNA sensing and IFN signaling pathways, they fail to induce specific interferon-stimulated genes (ISGs) in response to innate immune activation or type 1 IFN treatment. Jurkat cells latently infected with a fluorescent reporter HIV similarly demonstrate attenuated responses to type 1 IFN. Using bulk and single-cell RNA sequencing we applied a functional genomics approach and define ISG expression dynamics in latent HIV infection, including HIV-infected ART-suppressed primary CD4 + T cells. Our observations indicate that HIV latency and viral suppression each link with cell-intrinsic defects in specific ISG induction. We identify a set of ISGs for consideration as latency restriction factors whose expression and function could possibly mitigate establishing latent HIV infection.